OPTIMIZATION TREATMENT OF UROGENITAL DISORDERS IN MENOPAUSAL WOMEN
Abstract
The relevance of urogenital disorders will steadily increase. In recent years the problem of urination disorders on attention. The most common and difficult in terms of treatment is imperative (urgent) form of incontinence as part of overactive bladder (OAB) syndrom. The article presents the results of clinical trials on the effectiveness of combination therapy (tolterodine and topical forms of estriol) compared with monotherapy of m-cholinergic antagonists (tolterodine) in peri- and postmenopausal women with OAB. The study confirmed that local forms of hormone replacement therapy for peri- and postmenopausal women with OAB increases the efficacy of m-cholinoblokers.
About the Authors
E. I. Ermakova
Federal State Budget Institution «Research Center for Obstetrics, Gynecology and Perinatology» Ministry of Healthcare and Social Development of the Russian Federation
Russian Federation
Russian Federation
V. E. Balan
Federal State Budget Institution «Research Center for Obstetrics, Gynecology and Perinatology» Ministry of Healthcare and Social Development of the Russian Federation
Russian Federation
Russian Federation
References
1. Балан В.Е Урогенитальные расстройства в климактерии (клиника, диагностика, заместительная гормонотерапия): Дис. … докт. Мед. Наук. -М. -1988.
2. Балан В.Е., Гаджиева З.К. Нарушения мочеиспускания в климактерии и принципы их лечения//Русский медицинский журнал. -2000. -Т. 8. -№ 7. -С.
3. Великая С.В. Совершенствование диагностики и терапии императивных нарушений мочеиспускания у женщин с урогенитальными расстройствами в климактерии: Дисс. … канд. Мед. Наук. -М.-2003.
4. Вишневский Е.Л., Пушкарь Д.Ю., Лоран О.Б., Данилов В.В., Вишневский А.Е.//Урофлоуметрия. -М.: 2004. -С. 263; С. 176-183; 183-208.
5. Кулаков В.И., Аполихина И.А. Недержание мочи у женщин: новые возможности в диагностике и лечении//Гинекология. -2004. -Т. 4. -№ 3. -С. 103 -105.
6. Петрова В.Д. Недержание мочи у женщин (этиопатогенез, клиника, диагностика, лечение)//Дис. … докт. мед. наук. -М. -2005.
7. Пушкарь Д.Ю. Диагностика и лечение сложных и комбинированных форм недержания мочи у женщин: Автореф. дис. … д-ра мед. наук. -М., 1996. -34 с.
8. Сивков А.В., Ромих В.В. Фармакотерапия гиперактивного мочевого пузыря//Consilium medicum. -2002. -№ 7. -С. 348 -354.
9. Aggazzotti G., Pesce F., Grassi D., Fantuzzi G., Righi E., De Vita D., Santacroce S., Artibani W. Prevalence of urinary incontinence among institutionalized patients: a cross-sectional epidemiologic study in a midsized city in northern Italy//Urology. -2000. -V. 156. -№ 2. -P. 245 -249.
10. Cruz F. Vanilloid receptor and detrusor instability//Neurology and Urodynamics.-2009.-P. 29 -34.
11. Сardozo L., Lose., Vc Clish D., Versi E., de Koning Gans H. A systematic review of estrogens for recurrent urinary tract infections: third report of the hormones and urogenital therapy (HUT) committee//Int. Urogynecol J. Pelvic Floor Dysfunct. -2001. -12.-P. -P. 15 -20.
12. Сardozo L, Staskin D. Textbook of female urology and urogynaecology -2005. -P.183 -227.
13. Fitzgerald M.P., Brubaker L. Urinary incontinence symptom scores and urodynamic diagnoses.//Neurourol. Urodin. -2002. -21. -P. 30 -35.
14. Hann-Chorng Kuo,Hsin-Tzu Liu, Michael B. Chancellor Urinary Nerve Growth Factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence//Neurology and Urodynamics.-2009.-P. 24 -28.
15. Jackson S., James M., Abrams P/The effect of oestradiol jn vaginal collagen metabolism in postmenopausal women with genuine stress incontinence//BJOG. -2002. -Vol. 109. -P.339 -344.
16. Lingman K. Genuine stress incontinence//Current Obstet Gynecol. -2001. -Vol. 2. -P. 353-358.
17. Liu HT, Kuo HC. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention//Neurourol Urodyn. -2009.-28(1): Р.78-81.
18. Маdersbacher S., Haidinger G., Waldmuller J. Urinary incontinence in both sexes-prevalence rates, impact on quality of life and sexual life.//Eur. Urol. -2000. -V. 37. -P. 2.
19. Moller L.A., Lose G., Jorgensen T. Risk factors lower urinary tract symptoms in women 40 to 60 years of age//Obstet. Gynecol. -2000. -Vol. 96. -P. 446 -451.
20. Monz D., Pons M., Hampel C., Hunskaer S., Quail D., Samsioe G., Sykes D., Wagg A., Papanicolaou S. Patien -repoted impact of urinary incontinence. -Results from treatment seeking women in 14 European countries//Maturitas. -2005. -V. 52. -№ 2. -Р. 25 -28.
21. Moore K.H. Conservative management for urinary incontinence//Baillieres Best. Pract. Res. Clin. Obstet. Gynecol. -2000. -Vol. 14. -№ 2. -Р. 251 -289.
22. Stenberg F., Heimer G., Ulmsten U. The prevalence of urogenital symptoms in postmenopausal women//Maturitas. -1995. -№ 22. -Suppl. -P. 17-20.
23. Van de Vaart C.H. et al. The contribution of hysterectomy to the occurrence of urge and stress urinary incontinence symptoms//Br. J. Obstet Gynecol. -2002. -Vol. 109. -P. 149-151.
24. Yokoyama T., Kumon H., Nagai A. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder/Neurourol. Urodin.-2008.-V.27, P.417 -420
Review
For citations:
Ermakova E.I., Balan V.E. OPTIMIZATION TREATMENT OF UROGENITAL DISORDERS IN MENOPAUSAL WOMEN. Obstetrics, Gynecology and Reproduction. 2011;5(3):16-21. (In Russ.)
Views:
461
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
